50
Participants
Start Date
April 28, 2021
Primary Completion Date
August 31, 2024
Study Completion Date
September 15, 2025
Schirmer Strip
A tear-based screening assay for breast cancer developed and validated by Namida Lab, Inc., a high complexity CLIA certified lab. It consists of two parts: tear sample collection using a Schirmer Strip and a clinical lab-developed test that measures protein biomarkers for breast cancer screening.
UTMB Health, Galveston
Lead Sponsor
The University of Texas Medical Branch, Galveston
OTHER
Namida Lab
INDUSTRY